the non-protein amino acid beta-n-methylamino-l-alanine (bmaa) was first associated with the high incidence of amyotrophic lateral sclerosis/parkinsonism dementia complex (als/pdc) in guam, and has been implicated as a potential environmental factor in als, alzheimerâ€™s disease, and other neurodegenerative diseases.